Literature DB >> 7495293

Bone marrow neutrophilia and suppressed bone turnover in human interleukin-6 transgenic mice. A cellular relationship among hematopoietic cells, osteoblasts, and osteoclasts mediated by stromal cells in bone marrow.

H Kitamura1, H Kawata, F Takahashi, Y Higuchi, T Furuichi, H Ohkawa.   

Abstract

To elucidate the effect of interleukin-6 (IL-6) on bone and bone marrow (BM), human IL-6 transgenic mice (hIL-6 tgm) were produced. Their bone and BM were examined histologically, radiologically, histomorphometrically, and hematologically on a temporal basis. hIL-6 tgm showed histologically evident neutrophilia in BM. Increase in precursors of granulocytes and monocytes in hIL-6 tgm was demonstrated by an assay for colony forming unit in culture (CFU-C) of BM cells. Decrease in osteoblasts and osteoid and suppression of primary spongiosa formation were predominantly observed in hIL-6 tgm at 14 weeks old, the terminal stage of life for hIL-6 tgm. An assay for colony forming unit in fibroblastic (CFU-F) of BM cells revealed a decrease in osteoblast precursor (with regard to alkaline phosphatase-positive colonies) in hIL-6 tgm at 15 weeks old. Histomorphometry demonstrated a decrease of both osteoclast number and bone resorption in hIL-6 tgm. These results suggested that enhanced granulocytic hematopoiesis, suppressed bone turnover, and alteration of cellular population in stromal cells in BM occurred in hIL-6 tgm. Thus we provide new findings that facilitate understanding of cellular interrelationships among hematopoietic cells, osteoblasts, and osteoclasts mediated by stromal cells in BM.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7495293      PMCID: PMC1869934     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

1.  APPLICATION OF THE STEREOSPECIFIC INHIBITOR L-PHENYLALANINE TO THE ENZYMORPHOLOGY OF INTESTINAL ALKALINE PHOSPHATASE.

Authors:  K WATANABE; W H FISHMAN
Journal:  J Histochem Cytochem       Date:  1964-04       Impact factor: 2.479

Review 2.  Marrow stromal stem cells.

Authors:  M Owen
Journal:  J Cell Sci Suppl       Date:  1988

3.  In vivo hematologic effects of recombinant interleukin-6 on hematopoiesis and circulating numbers of RBCs and WBCs.

Authors:  T R Ulich; J del Castillo; K Z Guo
Journal:  Blood       Date:  1989-01       Impact factor: 22.113

4.  Osteoblastic cells are involved in osteoclast formation.

Authors:  N Takahashi; T Akatsu; N Udagawa; T Sasaki; A Yamaguchi; J M Moseley; T J Martin; T Suda
Journal:  Endocrinology       Date:  1988-11       Impact factor: 4.736

5.  Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis.

Authors:  C W Löwik; G van der Pluijm; H Bloys; K Hoekman; O L Bijvoet; L A Aarden; S E Papapoulos
Journal:  Biochem Biophys Res Commun       Date:  1989-08-15       Impact factor: 3.575

6.  Establishment of an interleukin 6 (IL 6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-IL 6 monoclonal antibodies.

Authors:  T Matsuda; T Hirano; T Kishimoto
Journal:  Eur J Immunol       Date:  1988-06       Impact factor: 5.532

7.  Generation of osteoclasts from isolated hematopoietic progenitor cells.

Authors:  N Kurihara; T Suda; Y Miura; H Nakauchi; H Kodama; K Hiura; Y Hakeda; M Kumegawa
Journal:  Blood       Date:  1989-09       Impact factor: 22.113

8.  Dissecting the hematopoietic microenvironment. VI. The effects of several growth factors on the in vitro growth of murine bone marrow CFU-F.

Authors:  Q R Wang; Z J Yan; N S Wolf
Journal:  Exp Hematol       Date:  1990-05       Impact factor: 3.084

9.  Human interleukin-6 supports granulocytic differentiation of hematopoietic progenitor cells and acts synergistically with GM-CSF.

Authors:  D Caracciolo; S C Clark; G Rovera
Journal:  Blood       Date:  1989-02-15       Impact factor: 22.113

10.  IgG1 plasmacytosis in interleukin 6 transgenic mice.

Authors:  S Suematsu; T Matsuda; K Aozasa; S Akira; N Nakano; S Ohno; J Miyazaki; K Yamamura; T Hirano; T Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

View more
  18 in total

Review 1.  Bone development: overview of bone cells and signaling.

Authors:  Anna Teti
Journal:  Curr Osteoporos Rep       Date:  2011-12       Impact factor: 5.096

2.  Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption.

Authors:  H Yoshitake; S R Rittling; D T Denhardt; M Noda
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

3.  SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis.

Authors:  Peter K K Wong; Paul J Egan; Ben A Croker; Kristy O'Donnell; Natalie A Sims; Sarah Drake; Hiu Kiu; Edward J McManus; Warren S Alexander; Andrew W Roberts; Ian P Wicks
Journal:  J Clin Invest       Date:  2006-05-18       Impact factor: 14.808

4.  Diet-dependent hypercalciuria in transgenic mice with reduced CLC5 chloride channel expression.

Authors:  V A Luyckx; B Leclercq; L K Dowland; A S Yu
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

5.  Callus mineralization and maturation are delayed during fracture healing in interleukin-6 knockout mice.

Authors:  Xu Yang; Benjamin F Ricciardi; Alexia Hernandez-Soria; Yuexian Shi; Nancy Pleshko Camacho; Mathias P G Bostrom
Journal:  Bone       Date:  2007-08-15       Impact factor: 4.398

6.  Serum from children with polyarticular juvenile idiopathic arthritis (pJIA) inhibits differentiation, mineralization and may increase apoptosis of human osteoblasts "in vitro".

Authors:  Valéria F Caparbo; Flávia Prada; Clóvis A A Silva; Paula L Regio; Rosa M R Pereira
Journal:  Clin Rheumatol       Date:  2008-08-07       Impact factor: 2.980

7.  Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways.

Authors:  Natalie A Sims; Brendan J Jenkins; Julian M W Quinn; Akira Nakamura; Markus Glatt; Matthew T Gillespie; Matthias Ernst; T John Martin
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

8.  Interleukin-6 deficiency corrects nephritis, lymphocyte abnormalities, and secondary Sjögren's syndrome features in lupus-prone Sle1.Yaa mice.

Authors:  Jacen S Maier-Moore; Christopher G Horton; Shirley A Mathews; Anthony W Confer; Christina Lawrence; Zijian Pan; K Mark Coggeshall; A Darise Farris
Journal:  Arthritis Rheumatol       Date:  2014-09       Impact factor: 10.995

9.  An experimental therapy to improve skeletal growth and prevent bone loss in a mouse model overexpressing IL-6.

Authors:  A Del Fattore; A Cappariello; M Capulli; N Rucci; M Muraca; F De Benedetti; A Teti
Journal:  Osteoporos Int       Date:  2013-08-14       Impact factor: 4.507

10.  Reduction of particle-induced osteolysis by interleukin-6 involves anti-inflammatory effect and inhibition of early osteoclast precursor differentiation.

Authors:  Michael Darowish; Ra'Kerry Rahman; Ping Li; Susan V Bukata; Jill Gelinas; Willis Huang; Lisa M Flick; Edward M Schwarz; Regis J O'Keefe
Journal:  Bone       Date:  2009-06-12       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.